Ethical conduct is critical in all business operations, but especially so in industries like life sciences, where health and safety are at stake. Codes of ethics can serve as a statement to outside stakeholders and policymakers about the types of behavior and business practices that an industry views as reasonable. This webinar will feature AdvaMed Vice President & Assistant General Counsel, Matt Wetzel, who will provide an in-depth look at the impact and necessity of industry codes of ethics – like the AdvaMed Code.
Participants can expect to learn:
• Why codes play an important role in shaping the standards and principles that companies consider to be appropriate and ethical;
• How following an industry code can assist medical device companies and entire industries compete on a level playing field; and
• How codes around the world are changing, and some recent shifts that may impact medical device companies.
Matthew E. Wetzel is Vice President & Assistant General Counsel of the Advanced Medical Technology Association (AdvaMed), the world’s largest trade association of medical device manufacturers. At AdvaMed, Mr. Wetzel advocates on behalf of the medical device industry with respect to legal reform, health care fraud and abuse, anti-bribery/anti-corruption measures, physician-industry transparency initiatives, and distribution licensure, among other issues. Most recently, Mr. Wetzel supported the launch of the AdvaMed Code of Ethics on Interactions with Health Care Professionals in China. He also oversees the Association’s amicus curiae program.
Prior to joining AdvaMed, Mr. Wetzel served as Senior Counsel, Global Compliance and Ethics at Boston Scientific Corporation. While there, he oversaw several critical elements of the company’s global compliance and privacy programs and advised on a variety of legal issues. Previously, Mr. Wetzel was as an Associate in the health care practices of Reed Smith LLP and Latham & Watkins LLP, both in Washington, D.C. Mr. Wetzel is a trained executive and career coach, a member of the American Health Lawyers Association Diversity & Inclusion Council, a Fellow of the Leadership Council on Legal Diversity, and a member of the Board of Directors of the LGBT Bar Association of D.C. He regularly speaks and writes on ethics and compliance issues in the life sciences industry.
Mr. Wetzel received his J.D., cum laude, and his A.B., magna cum laude, from Georgetown University.